Traditional risk factors n (%)

Variable

Total

(n = 83)

Stage 3

(n = 28)

Stage 4

(n = 13)

Stage 5

(n = 42)

P value

CVRF*

3.24 ± 1.24

3.29 ± 1.53

3.15 ± 0.89

3.23 ± 1.14

0.94

Hypertension

75 (90.36%)

25 (33.33%)

12 (16.00%)

38 (50.67%)

0.95

Abdominal obesity

66 (79.52%)

21 (31.82%)

11 (16.67%)

34 (51.52%)

0.73

Dyslipidemia

58 (69.88%)

16 (27.59%)

8 (13.79%)

34 (58.62%)

0.08

Diabetes

35 (42.17%)

11 (31.43%)

7 (20.00%)

17 (48.57%)

0.64

Obesity

19 (22.8%)

10 (52.63%)

3 (15.79%)

6 (31.58%)

0.09

Alcohol use

12 (14.46%)

8 (66.67%)

0 (0.00%)

4 (33.33%)

0.02

Tobacco use

3 (3.61%)

0 (0.00%)

1 (33.33%)

2 (66.67%)

0.40

Nontraditional risk factors n (%)

CVRF*

1.96 ± 0.78

1.64 ± 0.62

1.76 ± 1.09

2.23 ± 0.69

0.004

Anemia

65 (78.31)

19 (29.23%)

8 (13.32%)

38 (56.46%)

0.02

Hyperuricemia

58 (69.88%)

21 (36.21%)

8 (13.79%)

29 (50.00%)

0.67

Proteinuria

37 (44.58%)

7 (18.82%)

5 (13.51%)

25 (67.57%)

0.015

Ca X P

4 (4.88)

0 (0.00%)

1 (25%)

3 (75%)

0.33

Cardiovascular disease n (%)

CVD Total

58 (69.8%)

15 (25.8%)

8 (13.8%)

35 (60.3%)

0.02

LVH

40 (48.2%)

7 (17.5%)

7 (17.5%)

26 (65.0%)

0.009

CHD

25 (30.1%)

8 (32%)

0 (0.0%)

17 (68%)

0.02

HF

10 (12%)

4 (40%)

0 (0.0%)

6 (60%)

0.34

Stroke

6 (7.2%)

2 (33.3%)

2 (33.3%)

2 (33.3%)

0.43

PAD

4 (4.8%)

2 (50%)

2 (50%)

0 (0.0%)

0.06

AF

2 (2.4%)

0 (0.0%)

0 (0.0%)

2 (100%)

0.36